IL132651A0 - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity - Google Patents

Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity

Info

Publication number
IL132651A0
IL132651A0 IL13265198A IL13265198A IL132651A0 IL 132651 A0 IL132651 A0 IL 132651A0 IL 13265198 A IL13265198 A IL 13265198A IL 13265198 A IL13265198 A IL 13265198A IL 132651 A0 IL132651 A0 IL 132651A0
Authority
IL
Israel
Prior art keywords
antiviral
acitvity
pharmaceutical
glycyrrhizic acid
composition
Prior art date
Application number
IL13265198A
Other languages
English (en)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of IL132651A0 publication Critical patent/IL132651A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13265198A 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity IL132651A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
PCT/EP1998/002797 WO1998051334A1 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Publications (1)

Publication Number Publication Date
IL132651A0 true IL132651A0 (en) 2001-03-19

Family

ID=11377123

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13265198A IL132651A0 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity
IL132651A IL132651A (en) 1997-05-14 1999-10-29 Antiviral pharmaceutical preparation containing glyceric acid and at least one protein with antiviral activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132651A IL132651A (en) 1997-05-14 1999-10-29 Antiviral pharmaceutical preparation containing glyceric acid and at least one protein with antiviral activity

Country Status (27)

Country Link
US (1) US6329339B1 (it)
EP (1) EP0980254B1 (it)
JP (2) JP2001525814A (it)
KR (1) KR100592193B1 (it)
CN (1) CN1114447C (it)
AR (1) AR012849A1 (it)
AT (1) ATE212232T1 (it)
AU (1) AU740944B2 (it)
BG (1) BG64748B1 (it)
CA (1) CA2289550A1 (it)
CZ (1) CZ291932B6 (it)
DE (1) DE69803565T2 (it)
DK (1) DK0980254T3 (it)
EA (1) EA003126B1 (it)
ES (1) ES2170501T3 (it)
GE (1) GEP20022672B (it)
HK (1) HK1028347A1 (it)
HU (1) HU224956B1 (it)
IL (2) IL132651A0 (it)
IT (1) IT1291366B1 (it)
PL (1) PL189218B1 (it)
PT (1) PT980254E (it)
SK (1) SK283584B6 (it)
TR (1) TR199902730T2 (it)
UA (1) UA63955C2 (it)
WO (1) WO1998051334A1 (it)
ZA (1) ZA983917B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1499341A4 (en) * 2002-04-18 2010-10-27 Univ Iowa Res Found PROCESS FOR INHIBITING AND PROCESSING BIOLOGICAL FILMS USING METAL CHELATORS
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
JP4792392B2 (ja) * 2003-09-11 2011-10-12 コーナーストーン セラピューティクス インコーポレイテッド Ｈｍｇｂ１に対するモノクローナル抗体
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
US20080311122A1 (en) * 2005-11-28 2008-12-18 Medimmune, Llc Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
EP2608783B1 (en) * 2010-08-25 2018-09-19 Lurong Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
EP3419629A4 (en) * 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
US20230158124A1 (en) * 2020-04-27 2023-05-25 Guangzhou Century Clinical Research Co., Ltd Drug, food and application of anti-coronavirus infection
MX2021005280A (es) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
UA63955C2 (uk) 2004-02-16
CA2289550A1 (en) 1998-11-19
BG103968A (en) 2000-07-31
IT1291366B1 (it) 1999-01-07
JP2001525814A (ja) 2001-12-11
ITMI971119A0 (it) 1997-05-14
EP0980254B1 (en) 2002-01-23
AR012849A1 (es) 2000-11-22
PL189218B1 (pl) 2005-07-29
SK154499A3 (en) 2000-08-14
CZ399199A3 (cs) 2000-04-12
KR20010012419A (ko) 2001-02-15
HU224956B1 (en) 2006-04-28
KR100592193B1 (ko) 2006-06-23
EA199901024A1 (ru) 2000-06-26
HUP0002985A3 (en) 2001-04-28
ZA983917B (en) 1998-11-09
JP2009102370A (ja) 2009-05-14
ATE212232T1 (de) 2002-02-15
AU740944B2 (en) 2001-11-15
ES2170501T3 (es) 2002-08-01
HK1028347A1 (en) 2001-02-16
HUP0002985A2 (hu) 2001-01-29
AU7764698A (en) 1998-12-08
CN1255859A (zh) 2000-06-07
DE69803565D1 (de) 2002-03-14
EP0980254A1 (en) 2000-02-23
BG64748B1 (bg) 2006-02-28
EA003126B1 (ru) 2003-02-27
CN1114447C (zh) 2003-07-16
ITMI971119A1 (it) 1998-11-14
DE69803565T2 (de) 2002-08-08
IL132651A (en) 2006-10-31
SK283584B6 (sk) 2003-10-07
PL336802A1 (en) 2000-07-17
DK0980254T3 (da) 2002-05-06
CZ291932B6 (cs) 2003-06-18
WO1998051334A1 (en) 1998-11-19
GEP20022672B (en) 2002-04-25
US6329339B1 (en) 2001-12-11
TR199902730T2 (xx) 2000-02-21
PT980254E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
IL132651A0 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity
EP1242443A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
HUP0004930A3 (en) Ampoules and manufacture thereof
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
GB9705903D0 (en) VP22 Proteins and uses thereof
AU6905698A (en) Disposable garment with extendible wings
AU8016398A (en) Peptides with antiviral activity
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
ZA986756B (en) Modified polypeptides with high activity and reduced allergenicity
AU9001898A (en) Beta-fructofuranosidase and gene thereof
EP1017787A4 (en) METHOD FOR PRODUCING SQUARE DOUBLE-STRAND MONOFILAMENTS FOR USE IN EDGE CUTTERS
AU1891301A (en) Novel polypeptide and dna thereof
AU8168898A (en) Interferon stimulating protein and uses thereof
AU3511100A (en) Novel nucleic acids and polypeptides
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
IL136988A0 (en) Novel nucleic acid and polypeptide
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
HUP0201660A2 (en) Novel polypeptide and dna thereof
EP1124840A4 (en) OVAR-SPECIFIC GENES AND PROTEINS
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
IL144849A0 (en) Angiopoietin-related protein and nucleic acids
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
IL115996A0 (en) Fluorenyl-hydroxamic derivatives endowed with immunosuppresive and anti-inflammatory activity
EP1122312A4 (en) NEW WAR-1 PROTEIN AND ITS GENE
AU6976500A (en) Nrage nucleic acids and polypeptides and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed